Navigation Links
Sangart Initiates Phase 1b Study of MP4CO in Patients With Sickle Cell Disease
Date:1/12/2012

nts suffering from a sickle cell crisis. The strong preclinical data suggest that a clinical evaluation of MP4CO in patients could yield meaningful results," said Brian O'Callaghan, President and CEO of Sangart. "Along with our other investigational therapy, MP4OX, we remain committed to developing medicines designed to enhance the delivery of oxygen and other gases to tissues and organs."

Sickle cell disease is an inherited hemoglobin disorder affecting red blood cell circulation in millions of people around the world. People with sickle cell disease have red blood cells that contain mostly hemoglobin S, an abnormal type of hemoglobin. Due to the presence of hemoglobin S, these red blood cells become crescent or sickle-shaped and have difficulty passing through small blood vessels. When sickle-shaped cells block small blood vessels, less blood circulates through the body, causing severe pain and damage to tissues that do not receive a normal blood flow. This vaso-occlusion is known as a "sickle cell crisis".  There are currently no approved medications to treat sickle cell crises, and only symptomatic relief is available.

About MP4
Sangart's product platform is based on the MP4 molecule, an investigational biopharmaceutical product designed to enhance the perfusion of oxygen-deprived (ischemic) tissues and provide targeted oxygen delivery in the capillaries. Using a novel pegylation approach, Sangart produces the MP4 molecule designed at the optimal oxygen affinity, diffusion potential and molecular size to perfuse capillaries and target oxygen delivery to tissues specifically at risk of ischemia. MP4 can bind carbon monoxide for delivery to hemoglobin in red blood cells and heme proteins in tissues to provide anti-inflammatory and anti-apoptotic (anti-programmed cell death) effects. Once carbon monoxide has been released, MP4 takes up oxygen, when circulating through the lung, for delivery to ischemic tissues.

About Sangart<
'/>"/>

SOURCE Sangart, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Sangart Initiates Phase 2b Study of Oxygen Therapeutic Agent MP4OX in Severe Trauma Patients With Hemorrhagic Shock
2. Sangart Announces Closing of $50 Million Series G Financing
3. Sangart, Inc. Receives U.S. Orphan Drug Designation for use of MP4CO in Patients with Sickle Cell Disease
4. Sangart, Inc. Initiates Phase IIa Study of Oxygen Therapeutic Agent MP4OX in Severe Trauma Patients With Hemorrhagic Shock
5. Sangart Completes Enrollment in Phase III Study of Its Novel Blood Substitute Hemospan
6. Independent Data Safety Monitoring Board Recommends Continuation of Sangarts Pivotal Phase III Trials of Hemospan(R) Following Second Interim Review
7. Sangart, Inc. Initiates Dosing in Phase II Study of Hemospan(R) in Chronic Critical Limb Ischemia
8. Merrimack Pharmaceuticals Initiates Enrollment in Phase 1 Study of MM-151 in Patients with Refractory Advanced Solid Tumors
9. Sumagen Initiates Clinical Testing of Omnia Biologics Manufactured HIV Vaccine
10. Pfizer Initiates Phase 1 Clinical Trial for FVIIa Hemophilia Drug Candidate Developed by Catalyst Biosciences
11. Zimmer Initiates Quarterly Dividend and Announces New Share Repurchase Program
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/30/2014)... BURLINGTON, Mass. , Sept. 30, 2014  Decision ... (PV) devices in Brazil , ... and China (BRIC) will see ... techniques are increasingly favored over surgical procedures. Although revenues ... care resources, reimbursement challenges, prolonged device approval times and ...
(Date:9/30/2014)... 2014  Decision Resources Group finds that the Asia ... China , India , ... rate through 2023. Dental implant procedure volumes will grow as physicians ... Other key findings from Decision Resources Group,s coverage of ... , Dental implant penetration: Penetration of dental implants among ...
(Date:9/30/2014)... 2014  According to their CEO, Rob ... trials is going through a complete transformation with ... of the current clinical trial management process isn,t ... clinical trials, which will ultimately drive the prescription ... company has been recognized by the National Cancer ...
Breaking Medicine Technology:Brazilian, Russian, Indian and Chinese Markets for Peripheral Vascular Devices Will See Strong Expansion Through 2023 2Brazilian, Russian, Indian and Chinese Markets for Peripheral Vascular Devices Will See Strong Expansion Through 2023 3Asia Pacific Dental Implant Market Will Grow at a Strong Rate Through 2023 2Asia Pacific Dental Implant Market Will Grow at a Strong Rate Through 2023 3Small Denver Company Pharmatech driving a large revolution in how cancer clinical trials are managed 2
(Date:9/30/2014)... September 30, 2014 The American ... to help diabetics curb their sweet tooth, but the ... this September, suggests that zero-calorie sweeteners may actually ... diabetes. , The Weizmann Institute of Science in ... artificial sweeteners to mice, the mice developed glucose intolerance. ...
(Date:9/30/2014)... 30, 2014 VisitandCare.com reports ... has gone up more than 79 percent in 2014, ... company also reported total revenue tripled for its entirety ... company’s professional strategy has allowed them to partner with ... for patient comfort and privacy — with state-of-the-art surgical ...
(Date:9/30/2014)... Minn. (PRWEB) September 30, 2014 For ... to the apple orchard, pumpkin patch or annual festival. ... for fast-spreading viruses – like the respiratory infection Enterovirus ... in most children, a small percentage – especially children ... symptoms. Increased concern about the Enterovirus is prompting hospitals ...
(Date:9/30/2014)... White Plains, NY (PRWEB) September 30, 2014 ... (HPCW) recently hosted its annual “In Celebration” gala, ... furthering the nonprofit’s mission of striving to provide ... individuals and families facing a serious or life-limiting ... Westchester Country Club in Rye, NY and recognized ...
(Date:9/30/2014)... Columbus, Ohio (PRWEB) September 30, 2014 ... and new viral strains emerging every day, it’s ... disinfecting system. The EnviroShield system is an ... and allows applications to surface normally missed with ... a spray nozzle that adds an electrostatic negative ...
Breaking Medicine News(10 mins):Health News:Artificial Sweeteners May be Linked to Greater Diabetes Risk 2Health News:VisitandCare.com Announces Record Demand for Plastic Surgery in Turkey 2Health News:VisitandCare.com Announces Record Demand for Plastic Surgery in Turkey 3Health News:VisitandCare.com Announces Record Demand for Plastic Surgery in Turkey 4Health News:As Hospitals Combat Enterovirus Outbreaks, Patients and Families Turn to “Virtual Visits” with CaringBridge 2Health News:Hospice & Palliative Care of Westchester Honors Outstanding Individuals at Annual ‘In Celebration’ Gala 2Health News:Columbus Janitorial Company Announces New Disinfecting System for your workplace 2
... disease (PD) is a neurological disorder, according to ... the Journal of the American Academy ... disease also increases a person,s risk of experiencing ... Parkinson,s treatment plans include a multidisciplinary approach in ...
... Lunden, the nation,s,longest-running morning news anchor hosted ABC,s ... her tenure she reported from 26 countries, covered,four ... One of the most,visible women in the country, ... Americans about health and wellness through her books, ...
... MAKE IT FIT(TM),( http://www.youcanmakeitfit.com ), an online fitness and ... 2009 by donating,their services for almost nothing. Principals Stacy ... Magnolia state an annual membership to, www.youcanmakeitfit.com for ... hours of,8am to 8pm on Tuesday, January 6, 2009. ...
... the United States , , TUESDAY, Dec. 30 (HealthDay News) ... of Quebec, population 7 million-plus, more than $6.5 billion ... from Seattle to Tampa are costing the United States, ... director of the Institute for Sleep and Wake Disorders ...
... Experts offer tips on how to avoid injury while ... -- Clearing snow from your driveway and sidewalks can ... to take proper health and safety precautions, says the ... 2007, more than 118,000 people were treated in U.S. ...
... pay more attention to choosing the doctor, not the ... viewed as a safe and long-lasting way to alleviate ... procedure fails, the problem more often lies with surgical ... found. , , Dislocation of the implant was the most ...
Cached Medicine News:Health News:Parkinson's Disease Plays Havoc With Common Orthopaedic Conditions 2Health News:Parkinson's Disease Plays Havoc With Common Orthopaedic Conditions 3Health News:Joan Lunden Inks Three-Year Deal to Host Health Corner(R) Television Series 2Health News:MAKE IT FIT(TM) Offers Virtually Free Fitness Service to All Mississippi Residents on 'Make Mississippi Fit Day' 2Health News:Insomnia Costs Billions in Lost Productivity 2Health News:Insomnia Costs Billions in Lost Productivity 3Health News:Shovel Snow Safely 2Health News:Surgeons Often Are Blamed When Hip Replacements Fail 2Health News:Surgeons Often Are Blamed When Hip Replacements Fail 3
...
... The Slim-LOC Plate is a ... intervertebral body fixation. The Slim-LOC is ... design, modified by current market technology. ... versatility & integrated instrumentation. Reduced width ...
... Osmium is a cervical plate system ... spine. The implant provides for the ... the bone transplant has consolidated. Optimized ... and bicortical fixation. Maximum purchase also ...
... meet the clinical challenges of anterior cervical ... and the choice of fixed angle screws ... for ease of implantation in complex cases. ... the surgeon the versatility of creating a ...
Medicine Products: